What is the recommended treatment for Methicillin-Sensitive Staphylococcus aureus (MSSA) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Methicillin-Sensitive Staphylococcus aureus (MSSA) Infections

Beta-lactam antibiotics, specifically oxacillin, nafcillin, or cefazolin, are the recommended first-line treatments for MSSA infections due to their superior efficacy compared to vancomycin. 1

First-Line Treatment Options

  • Antistaphylococcal penicillins are the preferred treatment for MSSA infections:

    • Oxacillin: 250-500 mg IV every 4-6 hours for mild to moderate infections; 1 gram IV every 4-6 hours for severe infections 2
    • Nafcillin: 2 g IV every 6 hours 3
    • Dicloxacillin: 125-250 mg PO every 6 hours (mild to moderate infections) 4
  • Cefazolin is an effective alternative to antistaphylococcal penicillins:

    • 0.5-1 g IV every 8 hours 3
    • Particularly useful for patients with non-anaphylactic penicillin allergy 5

Treatment by Infection Type

Skin and Soft Tissue Infections

  • For simple abscesses or boils, incision and drainage may be adequate 3
  • For purulent cellulitis:
    • Clindamycin: 300-450 mg PO TID 3
    • TMP-SMX: 1-2 DS tablets PO BID 3
    • Doxycycline: 100 mg PO BID 3

Bacteremia and Endocarditis

  • For uncomplicated MSSA bacteremia: minimum 2 weeks of therapy 1
  • For complicated bacteremia: 4-6 weeks of therapy 1
  • For MSSA endocarditis: 6 weeks of nafcillin or oxacillin 3
  • Blood cultures should be obtained 2-4 days after initial positive cultures to document clearance of bacteremia 1

Pyomyositis

  • Cefazolin or antistaphylococcal penicillin (nafcillin or oxacillin) is recommended 3
  • Early drainage of purulent material is essential 3
  • Initial IV antibiotics, followed by oral antibiotics once clinically improved 3
  • Total duration of 2-3 weeks is recommended 3

Special Considerations

Penicillin Allergy

  • Patients with reported penicillin allergy should have their allergy evaluated 5
  • For non-anaphylactic penicillin allergy, cefazolin is preferred over vancomycin 5
  • For severe penicillin allergy, vancomycin is recommended 3

Pediatric Dosing

  • Oxacillin: 50-100 mg/kg/day IV in equally divided doses every 4-6 hours 2
  • Dicloxacillin: 12.5-25 mg/kg/day PO in equally divided doses every 6 hours 4
  • Clindamycin: 10-13 mg/kg/dose PO every 6-8 hours, not to exceed 40 mg/kg/day 3

Duration of Therapy

  • For severe staphylococcal infections: minimum 14 days 2
  • For endocarditis and osteomyelitis: 6 weeks or longer 3, 2
  • Continue therapy for at least 48 hours after patient becomes afebrile, asymptomatic, and cultures are negative 2

Common Pitfalls to Avoid

  • Using vancomycin for MSSA infections when beta-lactams can be used - beta-lactams have superior efficacy 1, 5
  • Inadequate duration of therapy, especially for complicated infections 2
  • Failure to obtain follow-up blood cultures to document clearance of bacteremia 1
  • Inadequate source control (e.g., drainage of abscesses, removal of infected devices) 1
  • Using once-daily antibiotics like ceftriaxone as primary therapy for MSSA bacteremia - evidence is insufficient 6

Monitoring

  • Assess clinical response within 48-72 hours of initiating therapy 7
  • Adjust antibiotics based on culture and susceptibility results 7, 1
  • For bacteremia, repeat blood cultures to document clearance 1

Beta-lactam antibiotics remain the cornerstone of MSSA treatment due to their superior efficacy and safety profile compared to alternatives like vancomycin 1, 8, 5.

References

Guideline

Treatment of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Guideline

Treatment of Staphylococcus aureus Tracheitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.